Zosano Pharma Corp
ZSANDelisted Jul 19, 2022- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001587221
Zosano Pharma Corp was delisted on Jul 19, 2022; its insiders filed their last Form 4 on Jun 7, 2022; 30 institutions reported holding it in 13F filings for Q1 2022, worth $2.89M in total; no superinvestor held it.
Key figures
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 30
- Q1 2022, −3 vs. previous quarter
- 13F value
- $2.89M
- Reported value at the end of Q1 2022
- Superinvestors holding
- 0
- At the end of Q1 2022
Superinvestors holding ZSAN, Q1 2022
No superinvestor reported holding ZSAN at the end of Q1 2022.
Latest insider trades
Open-market purchases and sales by Zosano Pharma Corp insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 7, 2022 (view filing) | Jun 6 | 1 day | Matthews ChristineChief Financial Officer | SSale | −82 | $0.71 | −$58.22 | −1.9%4.18K after | |
| Jun 7, 2022 (view filing) | Jun 6 | 1 day | Lo StevenChief Executive Officer | SSale | −442 | $0.71 | −$313.82 | −3.2%13.2K after | |
| Apr 1, 2022 (view filing)9:09 PM ET | Mar 31 | 1 day | Matthews ChristineChief Financial Officer | SSale | −8.12K | $0.2101 | −$1.71K | −5.3%146.4K after | |
| Apr 1, 2022 (view filing)9:08 PM ET | Mar 31 | 1 day | Kellerman Donald JVP, Clinical Dev & Med Affairs | SSale | −4.01K | $0.2101 | −$841.66 | −6.6%56.3K after | |
| Apr 1, 2022 (view filing)9:07 PM ET | Mar 31 | 1 day | Lo StevenChief Executive Officer | SSale | −23.6K | $0.2101 | −$4.97K | −4.9%460.7K after | |
| Nov 24, 2021 (view filing) | Nov 23 | 1 day | Greathouse KennethDirector | SSale | −10.0K | $0.60 | −$6.00K | −18.7%43.5K after |
Top 10 13F holders, Q1 2022
The largest institutional positions in Zosano Pharma Corp at the end of Q1 2022; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 5,148,907 | $1.16M | 0.00% | +818,272+18.9% | Added |
| Aisling Capital Management LP | 2,718,226 | $612.0K | 0.33% | 00.0% | Unchanged |
| BlackRock Inc. | 2,051,108 | $462.0K | 0.00% | +1,350+0.1% | Added |
| Geode Capital Management, LLC | 900,316 | $203.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 436,338 | $98.0K | 0.00% | +17,422+4.2% | Added |
| Renaissance Technologies LLC | 249,014 | $56.0K | 0.00% | +249,014 | New |
| Telemetry Investments, L.L.C. | 210,000 | $47.0K | 0.08% | +58,000+38.2% | Added |
| Northern Trust Corp | 199,497 | $45.0K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 150,000 | $34.0K | 0.00% | −150,000−50.0% | Reduced |
| UBS Group AG | 144,667 | $32.0K | 0.00% | +69,755+93.1% | Added |